Athyrium is a life science-focused investment firm that specializes in providing financial services to companies in the healthcare sector, including biotechnology and medical devices.

Athyrium Capital is a specialized asset management company with a focus on the global healthcare sector. Athyrium invests in a wide range of financial instruments including royalties, structured credit, and equities as well as select special situations.

Zealand Pharma

Kala Pharmaceuticals

Apollo Endosurgery

Biora Therapeutics

Sound Physicians

VillageMD

BioCryst Pharmaceuticals

Clover Health

Dermira

Halozyme Therapeutics

OptiNose

Travere Therapeutics

Revance Therapeutics

Portola Pharmaceuticals

Puma Biotechnology

Athyrium Capital Management, LP

Athyrium

COM:ATHYRIUM

Athyrium

Analysis Not Available